平安证券研报指出，新产业2025H1实现归母净利润7.71亿元，yoy-14.62%。单Q2实现归母净利润3.34亿元，yoy-30.06%。收入增长符合预期，国内市场受DRG/DIP改革和集采等影响短期业绩承压，海外市场表现亮眼。截至25H1末，公司产品服务的三级医院数量达到1,835家，三级医院覆盖率为47.60%，其中三甲医院的覆盖率达63.51%，为长期发展奠定基础。公司专注于体外诊断领域，坚定发展战略，持续拓展国内和海外市场，双轮驱动不断打开成长空间。由于集采等政策环境压力调整预测2025-2027年EPS为2.44、3.03、3.76元（原2025-2027年预测为2.69、3.32、4.10元），但考虑到公司近年来国内外装机数保持强劲、中大型机占比不断提升，且集采有望加速国产替代，持续带动试剂放量，维持“推荐”评级。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.